Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 5/20 | 1.00 |
| ▸ | GSK3B | P49841 | 9/20 | 0.67 |
| ▸ | NPC1 | O15118 | 1/20 | 0.60 |
| ▸ | RAB9A | P51151 | 1/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | ABL1 | P00519 | 1/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | ALPI | P09923 | 1/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | ALPG | P10696 | 1/20 | 0.58 |
| ▸ | APEX1 | P27695 | 1/20 | 0.58 |
| ▸ | CASP3 | P42574 | 1/20 | 0.58 |
| ▸ | RECQL | P46063 | 1/20 | 0.58 |
| ▸ | BLM | P54132 | 1/20 | 0.58 |
| ▸ | CASP7 | P55210 | 1/20 | 0.58 |
| ▸ | CASP6 | P55212 | 1/20 | 0.58 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.58 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5804589 | 0.98 | PTPN1 (0.95) | PTPN1GSK3BNPC1RAB9AKDM4E | |
| 4-Hydroxyacetophenone SCHEMBL4781559 | 0.89 | PTPN1 (0.80) | PTPN1GSK3BNPC1RAB9AKDM4E | |
| SCHEMBL205280 | 0.89 | GSK3B (0.80) | PTPN1GSK3BNPC1RAB9A | |
| SCHEMBL689331 | 0.82 | GSK3B (0.83) | PTPN1GSK3BRAB9AKDM4EALDH1A1 | |
| SCHEMBL28594745 | 0.82 | GSK3B (0.70) | PTPN1GSK3BALDH1A1ESR1ESR2 | |
| SCHEMBL27665801 | 0.81 | PTPN1 (0.68) | PTPN1NPC1RAB9AKDM4EALDH1A1 | |
| SCHEMBL247615 | 0.80 | GSK3B (0.70) | PTPN1GSK3BALDH1A1 | |
| SCHEMBL70930 | 0.80 | GSK3B (1.00) | PTPN1GSK3B | |
| SCHEMBL9909658 | 0.80 | GSK3B (0.67) | PTPN1GSK3BKDM4EALDH1A1ABL1 | |
| SCHEMBL3987484 | 0.79 | NPC1 (0.65) | PTPN1NPC1RAB9AKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1596 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260078296-A1 | SUSTAINED-RELEASE SCALE INHIBITORS | Materials Engineering and Technical Support Services (US) | 2026-03-19 | — | — | US | claimed |
| US-20250333698-A1 | SIRPa DEFICIENT MACROPHAGES FOR TREATING CANCER | UNIV GEORGIA STATE RES FOUND (US) | 2025-10-30 | — | — | US | claimed |
| CN-119930621-A | Fungus-inhibiting matrine hydrazine thiazole derivative and preparation method and application thereof | 南京林业大学 | 2025-05-06 | — | — | CN | claimed |
| CN-119371324-B | Preparation method of deuterium-labeled ractopamine hydrochloride-d 5 | 成都大道三灵生物科技有限公司 | 2025-03-14 | — | — | CN | claimed |
| CN-119371324-A | Preparation method of deuterium-labeled ractopamine hydrochloride-d 5 | 成都大道三灵生物科技有限公司 | 2025-01-28 | — | — | CN | claimed |
| US-20240374562-A1 | METHODS AND COMPOSITIONS COMPRISING A NITRITE-REDUCTASE PROMOTER FOR TREATMENT OF MEDICAL DISORDERS AND PRESERVATION OF BLOOD PRODUCTS | EPICENTRX, INC. (US) | 2024-11-14 | — | — | US | claimed |
| CN-118702556-A | Method for preparing medical intermediate from lignin and application thereof | 江苏大学 | 2024-09-27 | — | — | CN | claimed |
| CN-117865868-B | Functionalized molecule, preparation method and application thereof | 湖南大学 | 2024-09-06 | — | — | CN | claimed |
| EP-4423251-A1 | SIRP ALPHA DEFICIENT MACROPHAGES FOR TREATING CANCER | Georgia State University Research Foundation, Inc. (US) | 2024-09-04 | — | — | EP | claimed |
| CN-118530786-A | Film stripping liquid suitable for flexible circuit board and preparation method thereof | 深圳市天熙科技开发有限公司 | 2024-08-23 | — | — | CN | claimed |
| CN-1174830-A | Method for synthesizing lecdopamine | CHENGDU ORGANIC CHEM INST (CN) | 1998-03-04 | — | — | CN | claimed |
| US-5654330-A | CONTROLS GROWTH OF BACTERIA AND/OR FUNGI | BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) | 1997-08-05 | — | — | US | claimed |
| CN-1144455-A | Synergistic antimicrobial compositons containing halogenated acetophenone and organic acid | BUCKMAN LABOR INC (US) | 1997-03-05 | — | — | CN | claimed |
| EP-0741517-A1 | SYNERGISTIC ANTIMICROBIAL COMPOSITIONS CONTAINING A HALOGENATED ACETOPHENONE AND AN ORGANIC ACID | BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) | 1996-11-13 | — | — | EP | claimed |
| US-5527826-A | Synergistic antimicrobial compositions containing a halogenated acetophenone and an organic acid | BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) | 1996-06-18 | — | — | US | claimed |
| CN-1116620-A | Method for synthesis of beta-adrenomimetic excitant type fodder additive | CHENGDU ORGANIC CHEM INST (CN) | 1996-02-14 | — | — | CN | claimed |
| US-5441981-A | Synergistic antimicrobial compositions containing a halogenated acetophenone and an organic acid | BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) | 1995-08-15 | — | — | US | claimed |
| WO-1995020319-A1 | SYNERGISTIC ANTIMICROBIAL COMPOSITIONS CONTAINING A HALOGENATED ACETOPHENONE AND AN ORGANIC ACID | BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) | 1995-08-03 | — | — | WO | claimed |
| US-5107034-A | Bromination of 4-hydroxyacetophenone, treating with methoxide to produce alpha-methoxy-4-hydroxyacetophenone, reduction | HOECHST CELANESE CORPORATION (US) | 1992-04-21 | — | — | US | claimed |
| EP-0449602-A1 | Method for producing 4-(2'-methoxyethyl) phenol | HOECHST CELANESE CORPORATION (US) | 1991-10-02 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078296-A1 | SUSTAINED-RELEASE SCALE INHIBITORS | CEL, TST, CD44 | PTPN1 2949/4885GSK3B 486/4885NPC1 2745/4885 |
| US-20240374562-A1 | METHODS AND COMPOSITIONS COMPRISING A NITRITE-REDUCTASE PROMOTER FOR TREATMENT OF MEDICAL DISORDERS AND PRESERVATION OF BLOOD PRODUCTS | HBB, HBG2, HBZ | PTPN1 217/4885GSK3B 3255/4885NPC1 3911/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.